BiotechTube

Somatropin

Phase 3Completed
1 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Adult Growth Hormone Deficiency

Conditions

Adult Growth Hormone Deficiency

Trial Timeline

Jan 1, 2003 → May 1, 2006

NCT ID
NCT00191360

About Somatropin

Somatropin is a phase 3 stage product being developed by Eli Lilly for Adult Growth Hormone Deficiency. The current trial status is completed. This product is registered under clinical trial identifier NCT00191360. Target conditions include Adult Growth Hormone Deficiency.

What happened to similar drugs?

9 of 20 similar drugs in Adult Growth Hormone Deficiency were approved

Approved (9) Terminated (3) Active (10)
✅BenralizumabAstraZenecaApproved
✅FluMist + inactivated influenza vaccineAstraZenecaApproved
✅Saizen® solution for injection (referred as Saizen®)MerckApproved
✅Tacrolimus/Sirolimus + Tacrolimus/MMF + Neoral/SirolimusRocheApproved
✅Aztreonam lysineGilead SciencesApproved
✅maraviroc + Raltegravir + Darunavir/ritonavirPfizerApproved
✅SabrilLundbeckApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (4)

NCT IDPhaseStatus
NCT00191360Phase 3Completed
NCT00191529Phase 3Completed
NCT00406926Phase 3Completed
NCT00490191ApprovedCompleted

Competing Products

20 competing products in Adult Growth Hormone Deficiency

See all competitors
ProductCompanyStageHype Score
BBP-398 + sotorasibBridgeBio PharmaPhase 1
18
Daridorexant + PlaceboIdorsiaPhase 1
23
SON-1010 (IL12-FHAB)Sonnet BioTherapeuticsPhase 1
23
agenT-797MiNK TherapeuticsPhase 1
19
PegilodecakinEli LillyPhase 1
29
eFT226 + Sotorasib + Fulvestrant + Abemaciclib + TrastuzumabeFFECTOR TherapeuticsPhase 1/2
29
Lazertinib(G001) + Lazertinib(G002)YuhanPhase 1
29
Patritumab deruxtecanDaiichi SankyoPhase 2
27
DJ-927 + capecitabineDaiichi SankyoPhase 1
29
Valemetostat TosylateDaiichi SankyoPhase 2
35
RoxadustatAstellas PharmaPhase 1
29
ASP3325 + PlaceboAstellas PharmaPhase 1
29
TRK-100STPAstellas PharmaPhase 1
29
EnsitrelvirShionogiPhase 1
29
E6130 + PlaceboEisaiPhase 1
29
E7389 + E7389 + E7389EisaiPhase 1
29
Eribulin MesylateEisaiPhase 1
29
E2022 + E2022 + E2022 + E2022 + E2022EisaiPhase 1
29
Donepezil Hydrochloride + Donepezil Hydrochloride + Donepezil Hydrochloride + Donepezil HydrochlorideEisaiPhase 1
29
Donepezil Hydrochloride + Donepezil Hydrochloride + Donepezil HydrochlorideEisaiPhase 1
29